For current market leaders, sustained dominance will hinge on an ability to navigate an increasingly uncertain regulatory and pricing environment and manage quality and safety concerns amid heightened scrutiny of GLP-1 drugs long-term effects and off-label use
High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization
You can also have a BMI of at least 27 if you also have a weight-related health condition, such as high blood pressure, cardiovascular disease, or obstructive sleep apnoea
The decision should account for: Why Ozempic was prescribed and whether diabetes targets are being met Current dose, time at that dose, and adherence Nausea, vomiting, constipation, reflux, hydration, and nutrition Other glucose-lowering medications and hypoglycemia risk Kidney, gallbladder, pancreatic, eye, and thyroid-related history Whether the apparent plateau is confirmed by a reliable trend If a person is using semaglutide specifically for chronic weight management, a clinician may discuss whether an FDA-approved obesity treatment such as Wegovy, or another medication such as tirzepatide when appropriate, better matches the diagnosis and treatment goals